Replies to post #120094 on Biotech Values

[DewDiligence]

Monthly Branded and Generic Lovenox Scripts

I’ve converted Rocky’s weekly script numbers to average weekly
figures for each month, which gives a better picture of the trend.
Since the launch of generic Lovenox on 7/23/10, the generic has
increased the number of scripts and the script share in every
month and the script share is now about 85%. The big bump
in Mar 2011 is explained in #msg-62029438.

Moreover, the total number of branded+generic scripts is gradually
increasing, so the genericization of Lovenox is expanding the market
just as it is supposed to do.

 
                           Script 
         Avg Wkly Scripts  Share of 
 Month   Branded  Generic  Generic 
 0411      9,213   53,041   85.2%

0311 12,767 48,278 79.1%
0211 22,769 35,025 60.6%
0111 25,279 31,124 55.2%
1210 25,767 29,332 53.2%
1110 28,082 28,081 50.0%
1010 30,398 26,412 46.5%
0910 31,319 23,304 42.7%
0810 37,611 16,876 31.0%

[Rocky3]

Numbers for scripts, including only 2011 numbers (see old messages for more history):
Week Lov. m-en

1/7 24,002 28,768

1/14 25,301 31,571

1/21 25,538 31,724

1/28 26,276 32,433

2/4 25,443 32,047

2/11 24,938 33,172

2/18 22,003 36,072

2/25 18,692 38,809

3/4 17,078 42,449

3/11 12,312 48,809

3/18 10,838 50,608

3/25 10,801 51,246

4/1 9,857 52,659

4/8 9,682 53,107

4/15 9,059 53,509

4/22 8,829 53,357

4/29 8,636 52,572

5/6 8,657 52,733

5/13 8,553 53,351

5/20 8,514 52,350

5/27 8,410 52,624